PRKCZ hypermethylation plays a vital role in several diseases, such as type 2 diabetes mellitus [45], CTCF deletion syndrome [46], and postmenopausal osteoporosis [47]. This evidence concerns the gene CTCF and postmenopausal osteoporosis.